C61
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • PSA = 10 ng/ml • Gleason-Score = 6 • cT1c and cT2a • tumor in = 2 punch biopsies (min. 8 punch biopsies ) • = 50 % tumor / punch biopsy • life expectancy min. 10 yrs • Karnofsky-Index min. 80% or ECOG-Performance-Status 0-2 • written informed consent
Exclusion criteria
Exclusion criteria: • previous or planned partial oder radical prostatectomy • unsufficient knowledge of German language, • severe physical or psychological diseases that may constrain patients • systemic-neurological diseases (MS, parkinson, dementia).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| compliance / adherence during intervention period (diary, attendance time) | — |
Secondary
| Measure | Time frame |
|---|---|
| questionnaires: HRQoL (FACT-G, FACT-P) anxiety (STAI) depression (BDI) mindfulness (FFA) stress (PSS) barriers lifestly coping (COPE) Other: saliva cortisol pro- and anti-inflammatory cytonkines (plasma) all post-intervention (11 weeks) | — |
Countries
Germany
Contacts
Universität Duisburg-Essen, Lehrstuhl und Klinik für Naturheilkunde und Integrative Medizin, Knappschafts-Krankenhaus, Kliniken Essen-Mitte